PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.21%
Both yoy net incomes decline, with VUZI at -1480.67%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.13%
Some D&A expansion while VUZI is negative at -41.17%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
35.86%
Lower deferred tax growth vs. VUZI's 236.07%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
4.02%
Less SBC growth vs. VUZI's 742.39%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1600.00%
Both reduce yoy usage, with VUZI at -373.67%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-124.16%
AR is negative yoy while VUZI is 124.72%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-19.80%
Both reduce yoy inventory, with VUZI at -238.51%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
98.52%
A yoy AP increase while VUZI is negative at -93.95%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-143.48%
Negative yoy usage while VUZI is 1609.39%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
-24.25%
Both yoy CFO lines are negative, with VUZI at -51.41%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-63.59%
Both yoy lines negative, with VUZI at -12.22%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-897.06%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-67.53%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-8.01%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
207.14%
Growth well above VUZI's 20.28%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-289.20%
Both yoy lines negative, with VUZI at -12.22%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-54.59%
Negative yoy issuance while VUZI is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
72.18%
Buyback growth of 72.18% while VUZI is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.